Landos Biopharma Inc.

$LABP, a biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases is being acquired by AbbVie ($ABBV).

Share This Article

 

About the Author

Landos Biopharma Inc.

Joey Ramson